These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

837 related items for PubMed ID: 17441712

  • 1. Chloro half-sandwich osmium(II) complexes: influence of chelated N,N-ligands on hydrolysis, guanine binding, and cytotoxicity.
    Peacock AF, Habtemariam A, Moggach SA, Prescimone A, Parsons S, Sadler PJ.
    Inorg Chem; 2007 May 14; 46(10):4049-59. PubMed ID: 17441712
    [Abstract] [Full Text] [Related]

  • 2. Tuning the hydrolytic aqueous chemistry of osmium arene complexes with N,O-chelating ligands to achieve cancer cell cytotoxicity.
    Peacock AF, Parsons S, Sadler PJ.
    J Am Chem Soc; 2007 Mar 21; 129(11):3348-57. PubMed ID: 17319668
    [Abstract] [Full Text] [Related]

  • 3. Phenylazo-pyridine and phenylazo-pyrazole chlorido ruthenium(II) arene complexes: arene loss, aquation, and cancer cell cytotoxicity.
    Dougan SJ, Melchart M, Habtemariam A, Parsons S, Sadler PJ.
    Inorg Chem; 2006 Dec 25; 45(26):10882-94. PubMed ID: 17173447
    [Abstract] [Full Text] [Related]

  • 4. Tuning the reactivity of osmium(II) and ruthenium(II) arene complexes under physiological conditions.
    Peacock AF, Habtemariam A, Fernández R, Walland V, Fabbiani FP, Parsons S, Aird RE, Jodrell DI, Sadler PJ.
    J Am Chem Soc; 2006 Feb 08; 128(5):1739-48. PubMed ID: 16448150
    [Abstract] [Full Text] [Related]

  • 5. The contrasting chemistry and cancer cell cytotoxicity of bipyridine and bipyridinediol ruthenium(II) arene complexes.
    Bugarcic T, Habtemariam A, Stepankova J, Heringova P, Kasparkova J, Deeth RJ, Johnstone RD, Prescimone A, Parkin A, Parsons S, Brabec V, Sadler PJ.
    Inorg Chem; 2008 Dec 15; 47(24):11470-86. PubMed ID: 19007206
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Organometallic osmium(II) arene anticancer complexes containing picolinate derivatives.
    van Rijt SH, Peacock AF, Johnstone RD, Parsons S, Sadler PJ.
    Inorg Chem; 2009 Feb 16; 48(4):1753-62. PubMed ID: 19146436
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Organometallic ruthenium(II) diamine anticancer complexes: arene-nucleobase stacking and stereospecific hydrogen-bonding in guanine adducts.
    Chen H, Parkinson JA, Parsons S, Coxall RA, Gould RO, Sadler PJ.
    J Am Chem Soc; 2002 Mar 27; 124(12):3064-82. PubMed ID: 11902898
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Use of chelating ligands to tune the reactive site of half-sandwich ruthenium(II)-arene anticancer complexes.
    Fernández R, Melchart M, Habtemariam A, Parsons S, Sadler PJ.
    Chemistry; 2004 Oct 11; 10(20):5173-9. PubMed ID: 15372674
    [Abstract] [Full Text] [Related]

  • 13. Chlorido-, aqua-, 9-ethylguanine- and 9-ethyladenine-adducts of cytotoxic ruthenium arene complexes containing O,O-chelating ligands.
    Melchart M, Habtemariam A, Parsons S, Sadler PJ.
    J Inorg Biochem; 2007 Nov 11; 101(11-12):1903-12. PubMed ID: 17582501
    [Abstract] [Full Text] [Related]

  • 14. Synthesis, characterization, and in vitro evaluation of novel ruthenium(II) eta6-arene imidazole complexes.
    Vock CA, Scolaro C, Phillips AD, Scopelliti R, Sava G, Dyson PJ.
    J Med Chem; 2006 Sep 07; 49(18):5552-61. PubMed ID: 16942028
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Ruthenium(II) arene anticancer complexes with redox-active diamine ligands.
    Bugarcic T, Habtemariam A, Deeth RJ, Fabbiani FP, Parsons S, Sadler PJ.
    Inorg Chem; 2009 Oct 05; 48(19):9444-53. PubMed ID: 19780621
    [Abstract] [Full Text] [Related]

  • 17. Amide linkage isomerism as an activity switch for organometallic osmium and ruthenium anticancer complexes.
    van Rijt SH, Hebden AJ, Amaresekera T, Deeth RJ, Clarkson GJ, Parsons S, McGowan PC, Sadler PJ.
    J Med Chem; 2009 Dec 10; 52(23):7753-64. PubMed ID: 19791745
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. DNA interactions of monofunctional organometallic osmium(II) antitumor complexes in cell-free media.
    Kostrhunova H, Florian J, Novakova O, Peacock AF, Sadler PJ, Brabec V.
    J Med Chem; 2008 Jun 26; 51(12):3635-43. PubMed ID: 18494458
    [Abstract] [Full Text] [Related]

  • 20. Bipyrimidine ruthenium(II) arene complexes: structure, reactivity and cytotoxicity.
    Betanzos-Lara S, Novakova O, Deeth RJ, Pizarro AM, Clarkson GJ, Liskova B, Brabec V, Sadler PJ, Habtemariam A.
    J Biol Inorg Chem; 2012 Oct 26; 17(7):1033-51. PubMed ID: 22791215
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 42.